Glucagon-Like Peptide-1 Is Associated With Systemic Inflammation in Pediatric Patients Treated With Hematopoietic Stem Cell Transplantation

Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) are challenged with severe side effects, which are propagated by mucosal barrier disruption, and the related microbial translocation and systemic inflammation. Glucagon-like peptide-1 (GLP-1), a well-known incretin hormone...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebbesen, Maria, Kissow, Hannelouise, Hartmann, Bolette, Kielsen, Katrine, Sørensen, Kaspar, Stinson, Sara Elizabeth, Frithioff-Bøjsøe, Christine, Esmann Fonvig, Cilius, Holm, Jens-Christian, Hansen, Torben, Holst, Jens Juul, Müller, Klaus Gottlob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692255/
https://www.ncbi.nlm.nih.gov/pubmed/34956226
http://dx.doi.org/10.3389/fimmu.2021.793588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692255/
https://www.ncbi.nlm.nih.gov/pubmed/34956226
http://dx.doi.org/10.3389/fimmu.2021.793588

Ejemplares similares